P53-DNA Recognition

From Proteopedia

Revision as of 00:51, 4 July 2012 by Remo Rohs (Talk | contribs)
Jump to: navigation, search
This Sandbox is Reserved from 22 April 2012, through 31 August 2012 for use in the course "Protein DNA" taught by Remo_Rohs at the La Canada High School, USA. This reservation includes Sandbox Reserved 169 through Sandbox Reserved 170.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

This is a joint project of La Canada High School and University of Southern California students, mentored by Professor Remo Rohs.

Contents

A Base Pairing Variant Enhances p53 Binding to a Response Element

Introduction and Biological Role of the Tumor Suppressor p53

Figure 1: Crystal structure of a p53 DBD tetramer-DNA complex; PDB ID# 3KZ8.
Figure 1: Crystal structure of a p53 DBD tetramer-DNA complex; PDB ID# 3KZ8[1].
Image:P53-consensus.jpg
Figure 2: p53 consensus site; R= A or G, Y= C or T, and W=A or T.
Figure 3:  Frequency of p53 mutants associated with cancer derived from IARC TP53 database. Domain architecture; N-ter=N-terminal, DBD=DNA binding domain, Tet=Tetramerization, and C-ter=C-terminal domain. Intermediate regions are fairly disordered.
Figure 3: Frequency of p53 mutants associated with cancer derived from IARC TP53 database. Domain architecture; N-ter=N-terminal, DBD=DNA binding domain, Tet=Tetramerization, and C-ter=C-terminal domain. Intermediate regions are fairly disordered.

Also known as the Guardian of the Genome, the tumor suppressor p53 is central in the natural defense against human cancer. The protein is activated by stress factors that can compromise the genomic integrity of the cell, and this activation unleashes the function of p53 as transcription factor. It binds as a tetramer (Figure 1) to a large range of DNA response elements. The p53 consensus site (Figure 2) is formed by two decameric half-sites, each containing a core element (red), that are separated by a variable number of base pairs (blue).

Binding of p53 to different response elements leads to distinct biological responses, such as cell-cycle arrest, senescence, or apoptosis. These different pathways correspond, at least in part, to differences in p53-DNA binding affinity and stability, which are determined by specific protein-DNA interactions.

Mutations of p53 residues are associated with 50% of human cancers. Such mutations are predominantly located in the p53-DNA binding domain (DBD) based on an analysis of human tumors (Figure 3). Particularly, arginine residues in the p53-DNA interface were found in tumors with high frequencies.

Structural Description of p53-DNA Complex

Domain Architecture and Tetramerization

Drag the structure with the mouse to rotate
Personal tools